APREPITANT 125/80 CAPSULE

Aprepitant 125/80 Capsule is a prescription antiemetic medication designed to prevent nausea and vomiting caused by chemotherapy (CINV). This combination therapy ensures effective control of both acute and delayed chemotherapy-induced symptoms, improving patient comfort and quality of life during cancer treatment.

The pack contains a 125 mg capsule followed by 80 mg capsules for the subsequent days, providing a structured regimen that enhances the medication’s antiemetic effectiveness. Aprepitant works by blocking neurokinin-1 (NK1) receptors, which are involved in triggering nausea and vomiting.

Administered under strict medical supervision, Aprepitant Capsules are suitable for use in hospital and oncology clinic settings. Manufactured in compliance with pharmaceutical quality standards, this prescription-only medicine ensures consistent potency, safety, and therapeutic efficacy when used as part of a comprehensive antiemetic plan.

Product Feature

• Effective antiemetic therapy capsules.
• Contains aprepitant 125 mg & 80 mg.
• Used to prevent chemotherapy-induced nausea and vomiting.
• Neurokinin-1 (NK1) receptor antagonist.
• Oral capsule dosage form.
• Commonly used in combination with other antiemetics.
• Manufactured under strict pharmaceutical quality standards.
• Prescription-required medication.

How It Helps

• Prevents chemotherapy-induced nausea and vomiting (CINV).
• Controls both acute and delayed nausea effectively.
• Blocks neurokinin-1 (NK1) receptors to reduce nausea signals.
• Enhances patient comfort during cancer treatment.